These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 2599902)
41. Interstitial curietherapy in the conservative treatment of anal and rectal cancers. Papillon J; Montbarbon JF; Gerard JP; Chassard JL; Ardiet JM Int J Radiat Oncol Biol Phys; 1989 Dec; 17(6):1161-9. PubMed ID: 2599904 [TBL] [Abstract][Full Text] [Related]
42. Low-dose-rate interstitial brachytherapy boost for the treatment of anal canal cancers. Cordoba A; Escande A; Leroy T; Mirabel X; Coche-Dequéant B; Lartigau E Brachytherapy; 2017; 16(1):230-235. PubMed ID: 27600606 [TBL] [Abstract][Full Text] [Related]
43. Intensity-modulated radiation therapy with simultaneous integrated boost combined with concurrent chemotherapy for the treatment of anal cancer patients: 4-year results of a consecutive case series. Franco P; Mistrangelo M; Arcadipane F; Munoz F; Sciacero P; Spadi R; Migliaccio F; Angelini V; Bombaci S; Rondi N; Numico G; Ragona R; Cassoni P; Morino M; Racca P; Ricardi U Cancer Invest; 2015 Jul; 33(6):259-66. PubMed ID: 25950188 [TBL] [Abstract][Full Text] [Related]
44. Cancer of the anal canal: treatment with chemotherapy and low-dose radiation therapy. Smith DE; Shah KH; Rao AR; Frost DB; Latino F; Anderson PJ; Peddada AV; Kagan AR Radiology; 1994 May; 191(2):569-72. PubMed ID: 8153343 [TBL] [Abstract][Full Text] [Related]
45. Definitive chemoradiotherapy for anal canal cancer: single-center experience. Tachibana I; Nishimura Y; Inada M; Fukuda K; Ishikawa K; Nishikawa T; Yokokawa M; Nakamatsu K; Kanamori S; Hida JI Int J Clin Oncol; 2018 Dec; 23(6):1121-1126. PubMed ID: 29992389 [TBL] [Abstract][Full Text] [Related]
46. Prognosis of cloacogenic and squamous cancers of the anal canal. Salmon RJ; Zafrani B; Labib A; Asselain B; Girodet J Dis Colon Rectum; 1986 May; 29(5):336-40. PubMed ID: 3698757 [TBL] [Abstract][Full Text] [Related]
47. Definitive radiotherapy for squamous cell carcinoma of the anal canal. Rabbani AN; Zlotecki RA; Kirwan J; George TJ; Morris CG; Rout WR; Mendenhall WM Am J Clin Oncol; 2010 Feb; 33(1):47-51. PubMed ID: 19704368 [TBL] [Abstract][Full Text] [Related]
48. Experience with split-course external beam irradiation +/- chemotherapy and integrated Ir-192 high-dose-rate brachytherapy in the treatment of primary carcinomas of the anal canal. Kapp KS; Geyer E; Gebhart FH; Oechs AC; Berger A; Hebenstreit J; Stoeger H Int J Radiat Oncol Biol Phys; 2001 Mar; 49(4):997-1005. PubMed ID: 11240240 [TBL] [Abstract][Full Text] [Related]
49. Impact of clinical and therapeutic factors on major late complications after radiotherapy with or without concomitant chemotherapy for anal carcinoma. Allal AS; Mermillod B; Roth AD; Marti MC; Kurtz JM Int J Radiat Oncol Biol Phys; 1997 Dec; 39(5):1099-105. PubMed ID: 9392550 [TBL] [Abstract][Full Text] [Related]
50. Chemoradiation for adenocarcinoma of the anus. Papagikos M; Crane CH; Skibber J; Janjan NA; Feig B; Rodriguez-Bigas MA; Hung A; Wolff RA; Delclos M; Lin E; Cleary K Int J Radiat Oncol Biol Phys; 2003 Mar; 55(3):669-78. PubMed ID: 12573754 [TBL] [Abstract][Full Text] [Related]
52. Radical radiotherapy for carcinoma of the anal canal. Otim-Oyet D; Ford HT; Fisher C; Crow J; Horwich A Clin Oncol (R Coll Radiol); 1990 Mar; 2(2):84-9. PubMed ID: 2261398 [TBL] [Abstract][Full Text] [Related]
53. Reduced radiation dose for elective nodal irradiation in node-negative anal cancer: back to the roots? Henkenberens C; Meinecke D; Michael S; Bremer M; Christiansen H Strahlenther Onkol; 2015 Nov; 191(11):845-54. PubMed ID: 26307627 [TBL] [Abstract][Full Text] [Related]
54. Epidermoid anal cancer: treatment by radiation alone or by radiation and 5-fluorouracil with and without mitomycin C. Cummings BJ; Keane TJ; O'Sullivan B; Wong CS; Catton CN Int J Radiat Oncol Biol Phys; 1991 Oct; 21(5):1115-25. PubMed ID: 1938508 [TBL] [Abstract][Full Text] [Related]
55. Squamous cell carcinoma of the anal canal: patterns and predictors of failure and implications for intensity-modulated radiation treatment planning. Wright JL; Patil SM; Temple LK; Minsky BD; Saltz LB; Goodman KA Int J Radiat Oncol Biol Phys; 2010 Nov; 78(4):1064-72. PubMed ID: 20350793 [TBL] [Abstract][Full Text] [Related]
56. Results of abdominoperineal resections for failures after combination chemotherapy and radiation therapy for anal canal cancers. Zelnick RS; Haas PA; Ajlouni M; Szilagyi E; Fox TA Dis Colon Rectum; 1992 Jun; 35(6):574-7; discussion 577-8. PubMed ID: 1587176 [TBL] [Abstract][Full Text] [Related]
57. Size does matter: can we reduce the radiotherapy field size for selected cases of anal canal cancer undergoing chemoradiation? Crowley C; Winship AZ; Hawkins MA; Morris SL; Leslie MD Clin Oncol (R Coll Radiol); 2009 Jun; 21(5):376-9. PubMed ID: 19282157 [TBL] [Abstract][Full Text] [Related]
58. Anal epidermoid carcinoma: a population-based clinico-pathological study of 164 patients. Goldman S; Glimelius B; Påhlman L; Ståhle E; Wilander E Int J Colorectal Dis; 1988 Jun; 3(2):109-18. PubMed ID: 3411182 [TBL] [Abstract][Full Text] [Related]
59. Cancer of the anal canal: report on the experience of 61 patients. Dubois JB; Garrigues JM; Pujol H Int J Radiat Oncol Biol Phys; 1991 Mar; 20(3):575-80. PubMed ID: 1995543 [TBL] [Abstract][Full Text] [Related]
60. [Carcinoma of the anal canal--results of radical radiotherapy]. Radosević-Jelić Lj; Stojanović S; Durbaba M; Josifovski J; Krivokapić Z Acta Chir Iugosl; 2002; 49(2):79-83. PubMed ID: 12587476 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]